Among many of his laboratory’s achievements are identification of an incipient gene mutation causing benign lymphocytes to morph into malignant hematologic tumors, development of methods to genetically modify a patient’s tumor cells to target and kill the patient’s cancer (suicide gene) and fostering the development of an antibody that is now widely used to isolate and purify human stem-cell populations for wide clinical and therapeutic uses. He is an author on more than 100 scientific publications, a contributor to 3 books, and has procured 3 patents. He is a currently Medical Center Professor Emeritus of Medicine, Microbiology and Immunology, and Pediatrics, and a member of the Cancer Center’s Honorary Board. Wilmot Cancer Center and the Medical Scientist Training (MD/PhD) Program all of which were funded by the National Institutes of Health. He remained at the University of Rochester where he has served as the Associate Dean of Research, and in a variety of other leadership positions including Directorships of the Center on Aging, the James P. Published his first research report, the University of Illinois, Chicago and the University of Rochester. He received clinical and research training at the University of California San Francisco where he degrees at the State University ofNew York at Buffalo in 1963.
A native of Geneva, NY, George Abraham graduated from Hobart College in 1959 with a bachelor of science degree in mathematics and chemistry, and received the MS (mathematics) in 1961, and M.D.
0 kommentar(er)
